-
TEL AVIV (MarketWatch) -- Israeli stocks were mixed on Sunday, with strength in the banks, Ormat and Israel Chemicals offset by weakness in technology stocks like Kamada, Radvision and Ceragon Networks. Full Article at MarketWatch
-
TEL AVIV (MarketWatch) -- Israeli stocks rose gently on Wednesday, reflecting strength in Israel Chemicals and the drug makers, while banks and the telecom sector were mixed. Full Article at MarketWatch
-
A rendering shows the different data points and information that Orsus' Situator platform can integrate for an organization's security department. Full Article at Security Info Watch
-
When navigation systems started showing up in the center stacks of luxury vehicles, the new (at the time) tech typically would set owners back a couple grand or more (and still does). Full Article at AutoblogGreen
-
. NICE Systems Ltd. (Nasdaq: NICE; TASE: NICE) unit Actimize is working with Unisys (NYSE: UIS) to implement a financial fraud fighting system at Bancolombia, Colombia's largest bank. Full Article at Globes Online
-
NEW YORK, November 30 /PRNewswire-FirstCall/ -- Actimize, a NICE Systems (NASDAQ:NICE) company and the largest and broadest provider of a single financial crime, risk and compliance software platform for the financial services industry, and Unisys... Full Article at PR Newswire
-
2009-11-30 08:18:56 - analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward. Full Article at PR-Inside.com
-
TEL AVIV (MarketWatch) -- Israel stocks fell on Sunday, led by weakness in the banks as well as in Israel Chemicals and parent Israel Corp. Full Article at MarketWatch
-
NICE Systems, an Israel-based provider of physical security information management (PSIM) solutions, has agreed to purchase the security management assets of Orsus, maker of the Situator security management software platform, for $22 million. Full Article at Security Info Watch
-
Nice said it expects the deal to increase non-GAAP revenue by several million dollars in 2010 and to be accretive to non-GAAP EPS in Q4 2010, but to be slightly dilutive on a non-GAAP basis in each of the first three quarters of next year. Full Article at Barron's Online
